{"resourceType": "Composition", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/outcome-measure-report"], "versionId": "83", "lastUpdated": "2025-08-12T18:22:53.937Z"}, "title": "Outcome Measure Report for QUARTET USA Trial", "status": "final", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "OutcomeMeasureReport", "display": "OutcomeMeasureReport"}], "text": "Outcome Measure Report"}, "relatesTo": [{"type": "part-of", "targetReference": {"reference": "Composition/372776", "type": "Composition", "display": "Comparative Evidence Report for QUARTET USA Trial"}}, {"type": "cite-as", "targetMarkdown": "Outcome Measure Report for QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375280. Revised 2025-08-12. Available at: https://fevir.net/resources/Composition/375280. Computable resource at: https://fevir.net/FLI/DocumentForComposition375280."}], "url": "https://fevir.net/resources/Composition/375280", "date": "2025-08-12T18:22:53.937Z", "custodian": {"reference": "Organization/118079", "type": "Organization", "display": "Computable Publishing LLC"}, "id": "375280", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "375280", "assigner": {"display": "Computable Publishing LLC"}}], "author": [{"display": "Joanne Dehnbostel"}], "language": "en", "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-description", "valueMarkdown": "This is an example of an Outcome Measure Report describing the QUARTET USA Randomized Clinical Trial for the EBM on FHIR Implementation Guide."}], "section": [{"title": "Group List", "code": {"text": "GroupList"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "Group/375175", "type": "Group", "display": "QUARTET USA Trial Quadpill group"}, {"reference": "Group/375182", "type": "Group", "display": "QUARTET USA Trial Control Group"}, {"reference": "EvidenceVariable/375183", "type": "EvidenceVariable", "display": "GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Results for Systolic blood pressure at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "EvidenceVariable/375185", "type": "EvidenceVariable", "display": "Systolic blood pressure at 12 weeks"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "Evidence/375628", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"}, {"reference": "Evidence/375594", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"}, {"reference": "Evidence/375907", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Results for Diastolic blood pressure at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "EvidenceVariable/375186", "type": "EvidenceVariable", "display": "Diastolic blood pressure at 12 weeks"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "Evidence/375629", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"}, {"reference": "Evidence/375932", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"}, {"reference": "Evidence/375933", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Results for Medication Adherence at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "EvidenceVariable/375201", "type": "EvidenceVariable", "display": "Medication Adherence at 12 weeks"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "Evidence/379723", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Quadpill group"}, {"reference": "Evidence/379724", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Control Group"}, {"reference": "Evidence/379725", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Results for Hypertension Control at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "EvidenceVariable/375202", "type": "EvidenceVariable", "display": "Hypertension Control at 12 weeks"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "Evidence/379736", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Quadpill group"}, {"reference": "Evidence/379737", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Control Group"}, {"reference": "Evidence/379738", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Results for Add-on Amlodipine at 6 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "EvidenceVariable/375203", "type": "EvidenceVariable", "display": "Add-on Amlodipine at 6 weeks"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "Evidence/379739", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Quadpill group"}, {"reference": "Evidence/379740", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Control Group"}, {"reference": "Evidence/379741", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Results for Adverse event free and hypertension control at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "results", "display": "Results"}]}, "focus": {"reference": "EvidenceVariable/375278", "type": "EvidenceVariable", "display": "Adverse event free and hypertension control at 12 weeks"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "entry": [{"reference": "Evidence/379742", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Quadpill group"}, {"reference": "Evidence/379743", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Control Group"}, {"reference": "Evidence/379744", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}]}